A Highly Specific Substrate for NanoLUC Luciferase Furimazine Is Toxic in vitro and in vivo


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

The bioluminescent platform based on a genetically engineered luciferase NanoLuc and its synthetic substrate furimazine is widely used in modern molecular biology for optical imaging and therapy of deep tissue tumors. Taking into account the perspectives of using this system in molecular biology research, a detailed study of the toxicity of furimazine in vitro and in vivo is of great interest. In this work, the cytotoxicity of furimazine in vitro was studied using four different cell lines. Systemic toxicity of furimazine in vivo was investigated under conditions of prolonged administration of the substrate in animals. It has been found that seven-day intravenous injection of the substrate in animals causes hydropic dystrophy of liver and necrosis of hepatocytes. Splitting of the dose into several injections reduces hepatotoxicity of furimazine.

Негізгі сөздер

Авторлар туралы

V. Shipunova

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Хат алмасуға жауапты Автор.
Email: viktoriya.shipunova@phystech.edu
Ресей, Moscow, 119779

O. Shilova

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Email: viktoriya.shipunova@phystech.edu
Ресей, Moscow, 119779

E. Shramova

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Email: viktoriya.shipunova@phystech.edu
Ресей, Moscow, 119779

S. Deyev

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Email: viktoriya.shipunova@phystech.edu
Ресей, Moscow, 119779

G. Proshkina

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Email: viktoriya.shipunova@phystech.edu
Ресей, Moscow, 119779

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML

© Pleiades Publishing, Ltd., 2018